| |
|
|
|
NovaBay Pharmaceuticals Inc.  
|
|
0.5323 -0.034 (-0.06%) |
11-22 11:04 |
|
Open: |
0.56 |
Pre close: |
0.566 |
Target:
|
0.89
|
|
High: |
0.5603 |
Low: |
0.5233 |
Resistance:
|
0.76
0.93
|
|
Volume: |
141,563 |
Market Cap: |
15M |
Support:
|
0.48
0.40
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.59
 |
MACD |
MACD(12,26):
|
-0.01  |
|
MA(20): |
0.60 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
0.78 |
Stochastic Oscillator |
%K(14,3):
|
17.78 |
|
MA(250): |
1.04 |
%D(3): |
22.96 |
|
Average Volume(K) |
3-Month: |
112146
|
52-Week |
High:
|
4.04 |
|
10-Days: |
153409 |
Low: |
0.23 |
|
RSI |
RSI(14):
|
45.41 |
Change(%): |
-54.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.457 |
Return on Equity (ttm) |
-172.3 |
Shares Out. (M) |
27.90 |
|
EPS Est. Current Year |
-0.470 |
Return on Assets (ttm) |
-43.3 |
Shares Float (M) |
12.32 |
|
EPS Est. Next Year |
-0.090 |
PEG Ratio |
0.00 |
% Held by Insiders |
25.87 |
|
EPS Est. Next Quarter |
-0.030 |
Qtrly Rev. Growth |
-48.6 |
% Held by Institutions |
4.11 |
|
Forward EPS |
-0.170 |
Gross Profit (p.s.) |
0.395 |
Shares Short (K) |
663 |
|
Book Value (p.s.) |
0.120 |
EBITDA (p.s.) |
-0.306 |
P/E |
-1.20 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.58 |
|
Profit Margin |
-96.71 |
Operating Cash Flow
(M) |
-8.49 |
P/S |
1.22 |
|
Operating Margin |
-101.50 |
Levered Free Cash Flow
(M) |
-4.59 |
P/CF |
-1.81 |
|
|
|
|
|
|
